Kassem Bourgi

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

Kassem Bourgi, Peter F. Rebeiro, Megan Turner et al. · Clinical Infectious Diseases · 2019 · 327 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Kassem Bourgi, Cathy A. Jenkins, Peter F. Rebeiro et al. · Journal of the International AIDS Society · 2020 · 243 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada

Peter F. Rebeiro, Cathy A. Jenkins, Aihua Bian et al. · Clinical Infectious Diseases · 2020 · 102 citations · Full text

Public Health, Internal Medicine, Pharmacotherapy +16

Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan

Kassem Bourgi, Indira Brar, Kimberly Baker-Genaw · PLoS ONE · 2016 · 62 citations · Full text

Medicine, Community Health, Health Sciences +10

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens

Michael Leonard, Zinhle Cindi, Yuki Bradford et al. · Clinical Infectious Diseases · 2020 · 52 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17